Cervarix – Cervical Cancer Vaccine
Key Data:
Drug (brand/generic)
Cervarix
Company/licensee
GlaxoSmithKline
Therapy class
Prophylactic vaccine
Product description
Vaccine against HPV types 16 and 18
Current indication
Prevention of precancerous cervical lesions (high grade cervical intraepithelial neoplasia: CIN grades 2 and 3)
Market sector
Oncology
Development status
Approved in most major markets; pre-registration US
